Safety and efficacy of elvitegravir, dolutegravir, and raltegravir in a real-world cohort of treatment-naïve and -experienced patients

The aim of this retrospective cohort study was to compare safety, efficacy and rates and reasons of discontinuation of the 3 currently approved integrase strand transfer inhibitors (INSTIs) elvitegravir (EVG), dolutegravir (DTG), and raltegravir (RAL) in HIV-infected treatment-naïve and -experienced...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Medicine (Baltimore)
Autori principali: Brehm, Thomas Theo, Franz, Marleen, Hüfner, Anja, Hertling, Sandra, Schmiedel, Stefan, Degen, Olaf, Kreuels, Benno, Schulze zur Wiesch, Julian
Natura: Artigo
Lingua:Inglês
Pubblicazione: Wolters Kluwer Health 2019
Soggetti:
Research Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6708907/
https://ncbi.nlm.nih.gov/pubmed/31393378
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000016721
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi